High cholesterol (hyperlipidemia) is elevated levels of LDL cholesterol, triglycerides, or both in the bloodstream, which increases cardiovascular disease risk. Statins — particularly atorvastatin and rosuvastatin — are the cornerstone of first-line drug therapy for most patients, due to their proven ability to reduce LDL cholesterol and lower the risk of heart attack and stroke.
High Cholesterol: Medications, Treatment & Drug Guide
High cholesterol, or hyperlipidemia, refers to elevated levels of lipids — primarily LDL cholesterol, total cholesterol, or triglycerides — in the blood. Because cholesterol itself causes no symptoms, it is typically detected through a blood lipid panel and evaluated in the context of overall cardiovascular risk rather than the number alone.
Cholesterol is carried through the bloodstream in particles: low-density lipoprotein (LDL) deposits cholesterol in artery walls, contributing to atherosclerosis and plaque buildup. High-density lipoprotein (HDL) carries cholesterol back to the liver for clearance — higher HDL is generally protective. Triglycerides, a type of blood fat, are also measured and contribute independently to cardiovascular and pancreatic risk at very high levels.
Overview: Understanding Cholesterol & Cardiovascular Risk
Cardiovascular risk assessment guides treatment decisions more than any single cholesterol number. Clinicians use tools like the Pooled Cohort Equations to estimate 10-year risk of a major cardiovascular event, factoring in age, sex, blood pressure, smoking status, diabetes, and cholesterol levels together.
Lifestyle modifications — diet, physical activity, smoking cessation, and weight management — are foundational and recommended for all patients with elevated cholesterol, regardless of whether medication is started. The Mediterranean and DASH dietary patterns have the strongest evidence for lipid improvement. Dietary changes that reduce saturated fat and trans fat intake have the most direct effect on LDL cholesterol.
When lifestyle changes are insufficient or cardiovascular risk is high enough, medications are added. Statins have the largest body of evidence for reducing cardiovascular events and are the standard first-line pharmacologic therapy for the majority of patients with clinically significant hyperlipidemia.
First-Line Medications
These are the most commonly prescribed medications for high cholesterol. Each links to a full drug guide with mechanism, uses, side effects, and interactions.
Other Medications Used for High Cholesterol
When statins alone are insufficient or not tolerated, additional agents may be used:
- Ezetimibe — Reduces cholesterol absorption in the small intestine; often added to statin therapy for additional LDL lowering, or used alone in statin-intolerant patients.
- PCSK9 inhibitors (evolocumab, alirocumab) — Injectable monoclonal antibodies that dramatically lower LDL; reserved for high-risk patients or familial hypercholesterolemia when statins and ezetimibe are insufficient.
- Fibrates (fenofibrate, gemfibrozil) — Primarily target elevated triglycerides; occasionally used alongside statins, though the combination with gemfibrozil significantly raises the risk of statin-related muscle problems.
- Omega-3 fatty acids — Prescription-strength icosapentaenoic acid (Vascepa) has cardiovascular outcome data for patients with persistently high triglycerides despite statin therapy.
- Bile acid sequestrants (cholestyramine, colesevelam) — Lower LDL by preventing bile acid reabsorption; generally used as add-on therapy.
- Bempedoic acid — A newer oral agent that inhibits ATP citrate lyase, an enzyme upstream of HMG-CoA reductase; approved as an alternative or add-on for statin-intolerant patients.
Drug Classes Used
The cornerstone class for high cholesterol management is the statin family:
Statins work by competitively inhibiting HMG-CoA reductase, the rate-limiting enzyme in the liver's cholesterol synthesis pathway. When the liver produces less cholesterol internally, it upregulates LDL receptors on its surface to pull more LDL from the bloodstream — this dual mechanism produces substantial LDL reductions. High-intensity statins (atorvastatin and rosuvastatin at higher strengths) are preferred for patients at the highest cardiovascular risk.
Common Drug Interactions
Statin drug interactions can be clinically significant, particularly those affecting the cytochrome P450 enzyme system:
Grapefruit and grapefruit juice contain furanocoumarins that inhibit the CYP3A4 liver enzyme responsible for metabolizing atorvastatin, simvastatin, and lovastatin. This inhibition raises statin blood levels, increasing the risk of muscle toxicity. Simvastatin also has a well-documented interaction with amlodipine (a calcium channel blocker commonly prescribed for blood pressure and angina): amlodipine inhibits CYP3A4 and raises simvastatin exposure, which led the FDA to issue a prescribing restriction on the highest simvastatin strength when combined with amlodipine.
Other notable interactions include: gemfibrozil combined with statins (greatly increases myopathy risk), certain antibiotics (clarithromycin, erythromycin), antifungals (itraconazole, ketoconazole), and some immunosuppressants (cyclosporine) — all of which can raise statin levels by the same CYP3A4 pathway.
Side Effects to Watch For
Muscle-related side effects (statin-associated muscle symptoms, or SAMS) are the most clinically significant concern with statin therapy, ranging from mild aches to rare but serious rhabdomyolysis. Elevated liver enzymes, new-onset diabetes, and cognitive complaints are also reported. Most patients tolerate statins well, and the cardiovascular benefits substantially outweigh the risks for appropriate candidates.
Comparison Guides
Atorvastatin and rosuvastatin are both high-intensity statins but differ in their metabolism, interaction profiles, and evidence base. Atorvastatin is metabolized by CYP3A4 and is therefore subject to more drug and food interactions, while rosuvastatin is not significantly metabolized by CYP3A4 and is unaffected by grapefruit. Both have extensive evidence from large cardiovascular outcome trials.
Frequently Asked Questions
What is the most commonly prescribed medication for high cholesterol?
Statins are the most commonly prescribed class of cholesterol-lowering medications. Atorvastatin (Lipitor) and rosuvastatin (Crestor) are among the most frequently prescribed, as both are high-intensity statins capable of substantially reducing LDL cholesterol. The choice between statins depends on a patient's cardiovascular risk profile, other medications, and individual tolerability.
What is the difference between LDL and HDL cholesterol?
LDL (low-density lipoprotein) is often called "bad" cholesterol because elevated levels contribute to plaque buildup in arteries, increasing risk of heart attack and stroke. HDL (high-density lipoprotein) is called "good" cholesterol because it helps transport cholesterol away from arteries back to the liver for removal. Most cholesterol-lowering medications primarily target LDL reduction, though some therapies also raise HDL or lower triglycerides.
Why should I avoid grapefruit with certain statins?
Grapefruit and grapefruit juice contain compounds called furanocoumarins that inhibit CYP3A4, a liver enzyme responsible for metabolizing several statins including atorvastatin, simvastatin, and lovastatin. Blocking this enzyme causes statin blood levels to rise significantly, increasing the risk of side effects including muscle problems (myopathy) and, rarely, rhabdomyolysis. Rosuvastatin and pravastatin are not metabolized by CYP3A4 and are not meaningfully affected by grapefruit.
Do statins cause muscle pain and is it dangerous?
Muscle-related symptoms (statin-associated muscle symptoms, or SAMS) are the most common reason patients stop taking statins. Most cases involve mild to moderate muscle aches that resolve after stopping or switching statins. Rarely, statins can cause rhabdomyolysis — severe muscle breakdown that can damage the kidneys. Symptoms requiring prompt evaluation include severe muscle pain, weakness, or dark-colored urine. Risk is higher with drug interactions, high-intensity statins, and in older patients or those with kidney or thyroid conditions.
⚠ This article is for informational purposes only and does not constitute medical advice. All cholesterol management decisions, including whether to start or change medications, should be made with a qualified healthcare provider based on your individual cardiovascular risk profile.